Scientists at the University of Pennsylvania’s Perelman School of Medicine have demonstrated that chimeric antigen receptor (CAR) T cell therapy could offer a novel approach to treating atherosclerosis.
A study from Children’s Hospital of Philadelphia has uncovered rare but severe neurological side effects in children, adolescents, and young adults receiving CAR-T cell therapy for leukaemia, highlighting the need for further investigation into the complex mechanisms underlying these complications.
April 2024
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.